Accordingly, MUC2/GILZ co-expression has previously been observed in goblet cells and supports the inverse correlation observed here, as MUC2 was expressed whilst GILZ expression was downregulated in mucosal samples of active IBD [12]. Here, TSC22D3 is linked to inflammatory bowel disease.